What impact could protein stabilisation have for cancer patients?
The Drug Discovery World Podcast
Release Date: 05/07/2026
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a cancer drug demonstrated it could reduce tumours by as much as 55%. Elsewhere, AI was a recurrent theme in both clinical trials and drug development. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Terry Connolly and Shinta Cheng from K36 Therapeutics. K36 is a company developing first-in-class cancer therapeutics and their current lead asset is a treatment for multiple myeloma patients. Bruno speaks to Terry and Shinta about how their NSD2 inhibitors can treat cancer, how their approach compares to other biotechs, and why K36’s science could be applied to other therapeutic areas. You can listen below, or find The Drug Discovery World Podcast...
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a UK group accelerated efforts to develop a vaccine for Ebolavirus. Elsewhere, significant findings in colorectal and brain cancer could shape future cancer treatments. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a report showed patients in Europe face barriers to patient access. Elsewhere, Wellcome prizes are facilitating research in both tropical disease and mental health. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the DDW ‘In Conversation With’ series is available to listen to now. This week, Bruno Quinney speaks to Dr Juliana Maynard, Head of Translational Imaging at Medicines Discovery Catapult. MDC recently announced a partnership with the UK National Nuclear Lab, and Maynard's work is at the forefront of advances being made in radiopharmaceuticals. Bruno speaks to Juliana about investment in the radiopharmaceuticals industry, why radiopharmaceuticals are an exciting approach in the cancer treatment space, and what it would mean for patients if the UK becomes a radiopharma...
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, research uncovered new treatment pathways for hard to treat breast cancers. Elsewhere, therapies given the green light could combat type 2 diabetes and generalised myasthenia gravis. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made headlines through an acquisition and its cancer research venture. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Anthony Johnson and Matthew Fyfe from Outrun Therapeutics. Outrun is a biotech specialising in protein stabilisation, an approach being applied to treat HPV+ head and neck cancer. But what does protein stabilisation mean in practice? And what impact could the approach have for cancer patients? You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the UK made headlines for both the investment it has attracted and the clinical trial reforms it rolled out. Elsewhere, the world’s first antimalarial drug for newborns could soon address a critical unmet need. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, an obesity drug proved it could improve liver health independent of weight loss. Elsewhere, Lilly was back in the news for both its type 2 diabetes drug and the company’s latest acquisition. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe latest episode of the DDW ‘In Conversation With’ series is available to listen to below.
This week, Bruno Quinney speaks to Anthony Johnson and Matthew Fyfe from Outrun Therapeutics. Outrun is a biotech specialising in protein stabilisation, an approach being applied to treat HPV+ head and neck cancer.
But what does protein stabilisation mean in practice? And what impact could the approach have for cancer patients?
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.